Home

procaspase1

Procaspase-1 is the inactive zymogen form of caspase-1, an inflammatory cysteine protease that plays a central role in the innate immune response. It is synthesized as a single polypeptide containing an N-terminal caspase activation and recruitment domain (CARD) followed by a protease domain. After synthesis, procaspase-1 can dimerize and recruit to inflammasomes through CARD–CARD interactions, positioning it for activation.

Activation occurs when inflammasomes assemble in response to pathogenic or danger signals, bringing together sensor proteins

Procaspase-1 activity is tightly regulated; dysregulation can contribute to autoinflammatory diseases such as CAPS, gout, and

such
as
NLRP3,
AIM2,
or
NLRC4
and
the
adaptor
ASC.
Procaspase-1
undergoes
autoproteolytic
cleavage
at
specific
aspartate
residues,
generating
large
(p20)
and
small
(p10)
catalytic
subunits
that
assemble
into
an
active
caspase-1
tetramer.
Active
caspase-1
proteolytically
processes
pro-inflammatory
cytokines
pro-IL-1β
and
pro-IL-18
into
their
mature
forms
and
cleaves
gasdermin
D
(GSDMD),
triggering
pyroptotic
cell
death
and
cytokine
release.
atherosclerosis.
Pharmacological
inhibitors
of
caspase-1
and
genetic
studies
continue
to
define
its
role
in
inflammation
and
host
defense.
This
protease
is
a
central
node
linking
inflammasome
signaling
to
downstream
inflammatory
responses.